Inovio Pharmaceuticals, Inc. Revenue 2009–2025
Inovio Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Inovio Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Inovio Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 65343, a 86.64% decrease year-over-year.
- Inovio Pharmaceuticals, Inc. annual revenue for 2025 was 65343, a 69.99% decrease from 2024.
- Inovio Pharmaceuticals, Inc. annual revenue for 2024 was 217756, a 73.83% decrease from 2023.
- Inovio Pharmaceuticals, Inc. annual revenue for 2023 was 832010, a 91.89% decrease from 2022.
- Inovio Pharmaceuticals, Inc. annual revenue for 2022 was 10.3 M.
Inovio Pharmaceuticals, Inc. (INO) — Frequently Asked Questions
Inovio Pharmaceuticals, Inc. (INO) is a publicly traded US company. It has a market capitalization of $51M. In fiscal 2025 it reported revenue of $65,343 and net income of -$85M. Explore INO's stock price, financial statements, earnings history, margins and key ratios below.
What is Inovio Pharmaceuticals, Inc.'s market cap?
Inovio Pharmaceuticals, Inc. (INO) has a market capitalization of $51M.
What is the INO stock price?
INO trades at $1.09 (-0.91% on the day).
How much revenue does Inovio Pharmaceuticals, Inc. make?
Inovio Pharmaceuticals, Inc. reported revenue of $65,343 in fiscal 2025.
Is INO profitable?
In fiscal 2025, Inovio Pharmaceuticals, Inc. reported net income of -$85M.